Navigation Links
Interruption of Menstrual Cycle by Chemotherapy Associated with Improved Survival in Early Breast Cancer
Date:6/3/2010

Study Also Shows Significant Benefit of Longer-term Adjuvant Chemotherapy Regimen

Pittsburgh, PA (Vocus) June 3, 2010 -- Chemotherapy-induced amenorrhea in premenopausal women being treated for early stage breast cancer was associated with significantly improved patient survival, according to a study published this week in the New England Journal of Medicine by the National Surgical Adjuvant Breast and Bowel Project (NSABP) in collaboration with leading US cancer centers and cooperative cancer research groups. The NSABP is led by oncologists from Allegheny General Hospital (AGH) in Pittsburgh. The study also showed that a sequential administration of chemotherapeutic drugs significantly improves survival in women with early breast cancer compared to delivering the drugs concurrently.

According to Charles Geyer, MD, an AGH breast medical oncologist and one of the study’s lead authors, the development of amenorrhea during and after adjuvant chemotherapy is associated with clinically important side effects and impacts on the quality of life in premenopausal women with early breast cancer. Chemotherapy-induced amenorrhea occurs in 40-90% of premenopausal breast cancer patients depending on their age and the type of chemotherapy regimen.

Estrogen promotes the growth of endocrine responsive breast cancers, which comprise approximately three quarters of breast cancers. Studies focusing on premenopausal women with endocrine responsive tumors have previously shown an association between chemotherapy-induced amenorrhea and improved outcomes.

Amenorrhea occurs because the chemotherapy suppresses ovarian function which results in substantial declines in estrogen levels. Some of the benefit of chemotherapy in premenopausal women is thought to be related to this form of endocrine therapy. Such findings have led to specific clinical trials in premenopausal women with endocr
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Interruptions Make Doctors Lose Track of Tasks
2. Menstrual Cramps May Be Helped by New Drug
3. How to Say Goodbye to Premenstrual Syndrome (PMS) With the Click of a Button - A New Way to Avoid PMS
4. North Carolina Film Student Scores Big in Bicycle Safety Video Contest
5. Former Microsoft Employee Combines Passion For Technology With American Made Chris King Bicycle Parts
6. Motorcycle Cancer Risk and ELF EMF Radiation Invasion of Gastrointestinal Melatonin
7. Kramer Healthcare Technologies' RQi enterprise™ Revenue Cycle Solution Selected by Piedmont Healthcare
8. Motorcycle Fatalities Drop Sharply in U.S.
9. Tuba City Regional Health Care Corporation Selects Stockell Healthcare to Deploy Patient Access and Revenue Cycle Management Solution
10. Brain Cancer Survivor Will Cycle 4,170 Miles Across USA to Outsmart Disease
11. Greenway Medical Technologies Donates Electronic Health Record, Clinical Research and Revenue Cycle Solutions to Northern Kentucky University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Albany, NY (PRWEB) June 19, 2013 ... Global Industry Size, Market Share, Trends, Analysis and Forecast, ... worth USD 6.2 billion in the year 2011 and ... growing at a CAGR of 9.7% from 2011 to ... overall endoscopes market, contributing about USD 2,201 million for ...
(Date:6/19/2013)... treating stroke victims has been "time equals brain." That,s because ... a drug that dissolves the stroke-causing blood clot can make ... or lost. , But specific information has been ... drug known as a tissue plasminogen activator, or tPA ... most common type of stroke. , Now, a ...
(Date:6/19/2013)... MAYWOOD, Il. A Loyola University Chicago Niehoff School ... grant to study whether Vitamin D can improve mood ... study also will examine whether vitamin D supplementation can ... their diabetes. The grant is from the National Institute ... , Principal investigator Sue M. Penckofer, PhD, RN and ...
(Date:6/19/2013)... AquaPrint Solutions in Thomson, IL is proud to present ... Harley Davidson motorcycle gas tank. A couple of weeks ago, ... of taking a split tank motorcycle that had been roughed ... a work of art. , In October of 2012, ... that had been dipped in a water transfer printer with ...
(Date:6/19/2013)... 2013 Fit Body Boot Camp in ... a charity boot camp in order to support Orlando resident, ... boot camp franchise hosted the Brent Can Breathe fundraiser ... 75 boot camp participants and collected over $700. , Officially ... the second fundraiser held for Orlando local Brent Snyder, 24, ...
Breaking Medicine News(10 mins):Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:Loyola receives $1.5 million grant to study vitamin D for diabetes and depression 2Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2
... 1 issue of the journal Sleep indicates that ... remain vigilant and attentive deteriorated significantly after losing less than ... study suggests that even moderate reductions in sleep duration can ... the academic performance of children with ADHD. Results of ...
... This release is also available in Chinese on ... Despite the absence of Medicare coverage, hospital use of computed ... the rise, according to a study in the March issue of ... www.jacr.org ). Colorectal cancer is the second leading cause of ...
... dissection, the current standard surgical treatment for localized non-small ... stage cases , according to a study published in the ... (JTO), the official journal of the International Association for the ... is very low in early-stage cancers with a maximum standard ...
... adhesive patches is at the center of an agreement ... arm of Italian pharmaceutical leader Zambon Co., SpA, to ... ways to deliver oral medications directly to a targeted ... sponsored research agreement between Zcube and UCSF, but is ...
... By Serena Gordon HealthDay Reporter , MONDAY, ... fears soaring as quickly as a child,s rapidly rising temperature. ... Pediatrics (AAP) attempts to allay those fears by reminding parents ... against illness, and that lowering a fever may actually prolong ...
... , MONDAY, Feb. 28 (HealthDay News) -- Many American women ... treatment was tied to higher breast cancer risk. A sharp ... after. However, a new study suggests that the 2002-2003 ... continue through 2007. The data suggests that the drop ...
Cached Medicine News:Health News:Moderate sleep loss impairs vigilance and sustained attention in children with ADHD 2Health News:Moderate sleep loss impairs vigilance and sustained attention in children with ADHD 3Health News:Hospital use of virtual colonoscopy is on the rise, study suggests 2Health News:Lymph node dissection is not essential in small screen-detected lung cancers, new research shows 2Health News:UCSF collaborates with Zcube to develop new ways to deliver drugs 2Health News:Kids' Fevers May Not Always Need Treatment 2Health News:Kids' Fevers May Not Always Need Treatment 3Health News:Drop in Breast Cancer Among White Women May Have Stalled 2
(Date:6/19/2013)... Today MedeAnalytics, a leading provider of ... its Employer Group and Individual Business Analytics ... their employer groups an intuitive and insightful view ... drug claims, network utilization, and overall financial impact. ... "Employer Group and Individual Business Analytics ...
(Date:6/19/2013)... 2013  It may seem like an odd pairing: an ... But these were two of the most talked about topics ... Meeting & Expo that just convened in San ... by some of the top internal medicine experts in the ... research that can not only save lives, but help people ...
(Date:6/18/2013)... -- Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), a ... commercialization of novel bile acid therapeutics to treat chronic ... public offering of 1,730,000 shares of its common stock ... In addition, Intercept has granted the underwriters a 30-day ... of common stock. All of the shares ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... Cempra Pharmaceuticals, a developer of differentiated antibiotics, ... (IV) solithromycin demonstrates excellent tolerability and ... up to 800 mg.  Oral administration of solithromycin ... 1 studies.  The presentation will be at the ...
... Covance Inc. (NYSE: CVD ) today announced that ... Tuesday, May 10, 2011 at 3:00 p.m. ET.  Investors may ... .  In order to register and download any necessary software, ... headquarters in Princeton, New Jersey, is one of the world,s ...
Cached Medicine Technology:Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 2Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 3Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 4Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 5Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 6Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 7Covance to Present at Baird's 2011 Growth Stock Conference 2
... Sensor Intravascular Mikro-Tip Pressure Catheters; Millar ... dual pressure sensor catheters for simultaneous ... are suitable for measuring pressure gradients ... across a vascular stenosis. The catheters ...
... Dual Pressure Sensor Intravascular Mikro-Tip ... a line of dual pressure sensor ... measurements. These catheters are suitable for ... between chambers, or across a vascular ...
... TITAN, a high-resolution modular ultrasound solution. ... state of the art high-resolution imaging ... care. The TITAN system's modular design ... and mobile usage. , Point-of-care connectivity. ...
... The XTD Thrombectomy catheter is a ... remove thrombus from occluded hemodialysis access grafts. ... and consists of a rotatable, spiral shaft ... as a flexible, distal curved tip. In ...
Medicine Products: